FDA Grants Full Approval for Mirvetuximab Soravtansine-gynx (Elahere) for FRα positive, platinum-resistant epithelial ovarian with Robert Coleman, MD Ovarian 4 Mins Read2 The recent approval by the Food and Drug Administration (FDA) of mirvetuximab soravtansine-gynx (Elahere) marks a significant advancement in the…
